Activation of Wnt/β‐catenin pathway during hepatocyte growth factor–induced hepatomegaly in mice†
Open Access
- 27 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 44 (4), 992-1002
- https://doi.org/10.1002/hep.21317
Abstract
Hepatocyte growth factor (HGF) and β-catenin both play a crucial role in stimulating hepatocyte proliferation, but whether these 2 pathways cooperate in inducing hepatocyte proliferation is unclear. We have previously reported that β-catenin forms a complex with c-Met (HGF receptor) that undergoes dissociation because of β-catenin tyrosine phosphorylation on stimulation by HGF. It is also known that delivery of the human HGF gene cloned in a plasmid under a CMV promoter results in hepatomegaly in mice. In addition, recently characterized β-catenin transgenic mice also showed hepatomegaly. The present study was based on the hypothesis that HGF-induced hepatomegaly is mediated, at least in part, by activation of the Wnt/β-catenin pathway. Here we report that delivery of the human HGF gene delivery in mice led to hepatomegaly via β-catenin activation in the liver in 1- and 4-week studies. The mechanisms of β-catenin activation in the 1-week study included loss of c-Met–β-catenin association as well as canonical β-catenin activation, leading to its nuclear translocation. In the 4-week study, β-catenin activation was observed via canonical mechanisms, whereas the c-Met–β-catenin complex remained unchanged. In both studies there was an associated increase in the E-cadherin–β-catenin association at the membrane. In addition, we generated liver-specific β-catenin knockout mice, which demonstrated significantly smaller livers. HGF gene delivery failed to induce hepatomegaly in these β-catenin conditionally null mice. In conclusion, β-catenin- and HGF-mediated signaling pathways cooperate in hepatocyte proliferation, which may be crucial in liver development, regeneration following partial hepatectomy, and pathogenesis of hepatocellular carcinoma. (HEPATOLOGY 2006;44:992–1002.)Keywords
This publication has 28 references indexed in Scilit:
- Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinomaThe Esophagus, 2004
- Upregulated promitogenic signaling via cytokines and growth factors: potential mechanism of robust liver tissue repair in calorie-restricted rats upon toxic challenge.Toxicological Sciences, 2002
- Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver developmentHistochemistry and Cell Biology, 2001
- The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the ratHepatology, 2001
- Liver regenerationJournal of Hepatology, 2000
- Liver RegenerationScience, 1997
- Hepatocyte Growth Factor Levels in Liver and Serum Increase During Chemical HepatocarcinogenesisHepatology, 1996
- In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (oval) cells after administration of 2-acetylaminofluoreneHepatology, 1996
- Hepatocyte Growth Factor mRNA in Human Liver Cirrhosis as Evidenced by in situ HybridizationScandinavian Journal of Gastroenterology, 1996
- Serum hepatocyte growth factor levels in liver diseases: Clinical implicationsHepatology, 1995